NV

Nishant Vaish

Active Director Director DIN 01534398
DIN 01534398 First appointment Nov 2001 Primary industry Chemicals and Materials
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 3 historical roles
Total affiliations 5 Since Nov 2001
Shareholding value •••• Premium profile

About Nishant Vaish

Data last updated:

Nishant Vaish is a Director at Aryann Chemical Trading Private Limited (since 2020) and Director at Respipure Pharma Private Limited (since 2022). The companies operate in Chemicals and Materials, Pharma and Real Estate and Construction. The 2 current companies with reported revenue have a combined latest revenue of ₹1,582 Cr; the largest is Aryann Chemical Trading Private Limited at ₹1,581 Cr (FY 2025). Earlier, Nishant Vaish was an Additional Director at Trihal Pharma Private Limited (2022) and Director at Avisa Developers Private Limited (2021–2025) and 1 more.

DIN 01534398
Primary Designation Director
Industry Chemicals and Materials
First Appointment 12 Nov 2001
Oldest Company Age 6 yrs
Largest company Aryann Chemical Trading Private Limited · ₹1,581 Cr (FY 2025)
Combined revenue ₹1,582 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director07 Aug 20202020₹1,581 Cr (FY 2025)Active
Respipure Pharma Private Limited U24290MH2022PTC375528
Director27 Jan 20222022₹45.4 Lakh (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Trihal Pharma Private Limited U24290MH2021PTC359068
Additional Director01 Feb 20222021₹4.36 Cr (FY 2025)Active
Avisa Developers Private Limited U45309MH2021PTC357053
Director15 Mar 20212021₹53.5 Lakh (FY 2025)Active
Yug International Private Limited U46691UP1997PTC021784
Director12 Nov 20011997₹862 Cr (FY 2024)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Respipure Pharma Private Limited
Aryann Chemical Trading Private Limited
Trihal Pharma Private Limited
Avisa Developers Private Limited
Premium access

Shareholding and investment profile for Nishant Vaish

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nishant Vaish

Nishant Vaish currently holds 2 directorships: Aryann Chemical Trading Private Limited (Director, since 07 Aug 2020, revenue ₹1,581 Cr (FY 2025)); Respipure Pharma Private Limited (Director, since 27 Jan 2022, revenue ₹45.4 Lakh (FY 2025)).

Nishant Vaish was first appointed on 12 Nov 2001 as Director at Yug International Private Limited. The most recent appointment on record is 01 Feb 2022 at Trihal Pharma Private Limited.

The 2 current companies of Nishant Vaish that report revenue have a combined latest revenue of ₹1,582 Cr: Aryann Chemical Trading Private Limited ₹1,581 Cr (FY 2025); Respipure Pharma Private Limited ₹45.4 Lakh (FY 2025).

Nishant Vaish held 3 earlier board appointments: Trihal Pharma Private Limited (Additional Director, 01 Feb 2022 to 24 Jun 2022); Avisa Developers Private Limited (Director, 15 Mar 2021 to 10 Jun 2025); Yug International Private Limited (Director, 12 Nov 2001 to 28 Jan 2022).

The current boards of Nishant Vaish's companies include Amit Bansal (Aryann Chemical Trading Private Limited), Madhur Vinodkumar Gupta (Aryann Chemical Trading Private Limited), Manish Shah Mangilal (Respipure Pharma Private Limited), Shekhar Shrawankumar Bhuwania (Respipure Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available